| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6830907 | Seizure | 2015 | 4 Pages |
Abstract
In conclusion, there is a paucity of data on the costs of SE. Further studies are warranted to determine costs, its predictors, quality of life, mortality data due to SE and its sequelae and to provide a basis for further cost-effectiveness calculations for new drugs and other interventions in SE and prolonged seizures.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Lena-Marie Kortland, Susanne Knake, Felix Rosenow, Adam Strzelczyk,